SMP-3124LP in Adults With Advanced Solid Tumors

NCT06526819 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: SMP3124LP

Sponsor

Sumitomo Pharma America, Inc.